Bright Minds Biosciences (DRUG) - 2023 Q3 - Quarterly Report

Bright Minds Biosciences Inc. Condensed Interim Consolidated Financial Statements For the three and nine months ended June 30, 2023 and 2022 (Expressed in Canadian Dollars) 1 | Page Bright Minds Biosciences Inc. Condensed Interim Consolidated Statements of Financial Position (Expressed in Canadian dollars) | | | June 30, | September 30, | | --- | --- | --- | --- | | | | 2023 | 2022 | | As at | Notes | (unaudited) | (audited) | | | | $ | $ | | ASSETS | | | | | Current Assets | | | | | Cash and cash equivalen ...